Browse By Cell Line Result Page of OvirusTdb

The total number of records retrieved from this search are 9. Click on ID to see further detail.
IDOV_1730Virus nameParovirusVirus strainH-1PVVirus genome typeDNAVirus familyParoviridaeVirus genome modificationNoneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineATCCOrigin of cell lineHuman neuroblastoma cell lineCell lineSK-N-MCConcentration of cell line7.6E+3 cells per wellIn-vitro toxicityNAAssayMTT assayIn-vitro virus concentration0.001 MOIIn-vitro result100% cell survivalModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedCell cycle arrest at G2 phase and induction of apoptosis by virusImmunogenic effectNAClinical trialNAPMID20087864
IDOV_1731Virus nameParovirusVirus strainH-1PVVirus genome typeDNAVirus familyParoviridaeVirus genome modificationNoneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineATCCOrigin of cell lineHuman neuroblastoma cell lineCell lineSK-N-MCConcentration of cell line7.6E+3 cells per wellIn-vitro toxicityNAAssayMTT assayIn-vitro virus concentration0.01 MOIIn-vitro result100% cell survivalModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedCell cycle arrest at G2 phase and induction of apoptosis by virusImmunogenic effectNAClinical trialNAPMID20087864
IDOV_1732Virus nameParovirusVirus strainH-1PVVirus genome typeDNAVirus familyParoviridaeVirus genome modificationNoneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineATCCOrigin of cell lineHuman neuroblastoma cell lineCell lineSK-N-MCConcentration of cell line7.6E+3 cells per wellIn-vitro toxicityNAAssayMTT assayIn-vitro virus concentration0.1 MOIIn-vitro result50% cell survivalModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedCell cycle arrest at G2 phase and induction of apoptosis by virusImmunogenic effectNAClinical trialNAPMID20087864
IDOV_1733Virus nameParovirusVirus strainH-1PVVirus genome typeDNAVirus familyParoviridaeVirus genome modificationNoneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineATCCOrigin of cell lineHuman neuroblastoma cell lineCell lineSK-N-MCConcentration of cell line7.6E+3 cells per wellIn-vitro toxicityNAAssayMTT assayIn-vitro virus concentration1 MOIIn-vitro result30% cell survivalModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedCell cycle arrest at G2 phase and induction of apoptosis by virusImmunogenic effectNAClinical trialNAPMID20087864
IDOV_1734Virus nameParovirusVirus strainH-1PVVirus genome typeDNAVirus familyParoviridaeVirus genome modificationNoneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineATCCOrigin of cell lineHuman neuroblastoma cell lineCell lineSK-N-MCConcentration of cell line7.6E+3 cells per wellIn-vitro toxicityNAAssayMTT assayIn-vitro virus concentration5 MOIIn-vitro result20% cell survivalModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedCell cycle arrest at G2 phase and induction of apoptosis by virusImmunogenic effectNAClinical trialNAPMID20087864
IDOV_1735Virus nameParovirusVirus strainH-1PVVirus genome typeDNAVirus familyParoviridaeVirus genome modificationNoneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineATCCOrigin of cell lineHuman neuroblastoma cell lineCell lineSK-N-MCConcentration of cell line7.6E+3 cells per wellIn-vitro toxicityNAAssayMTT assayIn-vitro virus concentration10 MOIIn-vitro result20% cell survivalModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedCell cycle arrest at G2 phase and induction of apoptosis by virusImmunogenic effectNAClinical trialNAPMID20087864
IDOV_1736Virus nameParovirusVirus strainH-1PVVirus genome typeDNAVirus familyParoviridaeVirus genome modificationNoneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineATCCOrigin of cell lineHuman neuroblastoma cell lineCell lineSK-N-MCConcentration of cell line7.6E+3 cells per wellIn-vitro toxicityNAAssayMTT assayIn-vitro virus concentration50 MOIIn-vitro result1% cell survivalModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedCell cycle arrest at G2 phase and induction of apoptosis by virusImmunogenic effectNAClinical trialNAPMID20087864
IDOV_5630Virus nameNewcastle disease virusVirus strainNDV-MK107Virus genome typeRNAVirus familyParamyxoviridaeVirus genome modificationNoneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineNAOrigin of cell lineHuman neuroepithelioma cell lineCell lineSK-N-MCConcentration of cell line80% confluencyIn-vitro toxicityNAAssayMTT assayIn-vitro virus concentration20 pfuIn-vitro result50% of cancer cell death occursModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedInduction of apoptosis by virus infectionImmunogenic effectInduction of IFN-Gamma productionClinical trialNAPMIDUS7470426
IDOV_5850Virus nameNewcastle disease virusVirus strainNDV-PPMK107Virus genome typeRNAVirus familyParamyxoviridaeVirus genome modificationNoneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineNAOrigin of cell lineHuman neuroepithelia cancer cell lineCell lineSK-N-MCConcentration of cell line80% confluencyIn-vitro toxicityNAAssayNAIn-vitro virus concentration20 pfuIn-vitro result50% cancer cell deathModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedNAImmunogenic effectNAClinical trialNAPMIDUS8105578